Alvotech (ALVOW) — research page

US · us-cm-kg/NASDAQ/ALVOW · as of 2026-11-08

Identity and listing

The issuer is Alvotech, listed on NASDAQ under ticker ALVOW, with ISIN USL018001168. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-N4 was found. The security type is Non-operating entity type (other), the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is Luxembourg. The issuer is listed and not halted.

The disclosure read

The record holds 39 filings in the twelve months from 2025-11-08 to 2026-11-08, across 35 filing days, of which 2 are prospectus, 4 are regulatory filing and 33 are results. The median gap between filing days is 6.5 days. The latest filing is dated 2026-10-20, is of type results, and was made 19 days before the record date of 2026-11-08. On NASDAQ the median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. In the sector 2836 Biological Products, (No Diagnostic Substances) the median cadence gap is 5.5 days across 176 issuers, with a median of 65.5 filings and a median latency of 4.0 days.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, as no dei:AuditorName tag is carried on the latest annual report cover, and foreign private issuers and older filings carry none. The auditor location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 9 research houses: Barclays, BofA Securities, Deutsche Bank, DNB Carnegie, Evercore ISI, IFS Reitun, Morgan Stanley, SEB and UBS.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0001898416.json (identity.jurisdiction)

10.4

https://mcp.us-cm-kg.ai/events/NASDAQ/ALVOW (the disclosure lines)

10.5

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.6

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.7

https://www.alvotech.com/analyst-coverage (coverage)

10.8

https://mcp.us-cm-kg.ai/record/NASDAQ/ALVOW (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"USL018001168"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:618173738e03df92.